Characterizing Adeno-Associated Virus Capsids with Both Denaturing and Intact Analysis Methods.


Journal

Journal of the American Society for Mass Spectrometry
ISSN: 1879-1123
Titre abrégé: J Am Soc Mass Spectrom
Pays: United States
ID NLM: 9010412

Informations de publication

Date de publication:
06 Dec 2023
Historique:
medline: 7 12 2023
pubmed: 27 11 2023
entrez: 27 11 2023
Statut: ppublish

Résumé

Adeno-associated virus (AAV) capsids are among the leading gene delivery platforms used to treat a vast array of human diseases and conditions. AAVs exist in a variety of serotypes due to differences in viral protein (VP) sequences with distinct serotypes targeting specific cells and tissues. As the utility of AAVs in gene therapy increases, ensuring their specific composition is imperative for the correct targeting and gene delivery. From a quality control perspective, current analytical tools are limited in their selectivity for viral protein (VP) subunits due to their sequence similarities, instrumental difficulties in assessing the large molecular weights of intact capsids, and the uncertainty in distinguishing empty and filled capsids. To address these challenges, we combined two distinct analytical workflows that assess the intact capsids and VP subunits separately. First, a selective temporal overview of resonant ion (STORI)-based charge detection-mass spectrometry (CD-MS) was applied for characterization of the intact capsids. Liquid chromatography, ion mobility spectrometry, and mass spectrometry (LC-IMS-MS) separations were then used for the capsid denaturing measurements. This multimethod combination was applied to three AAV serotypes (AAV2, AAV6, and AAV8) to evaluate their intact empty and filled capsid ratios and then examine the distinct VP sequences and modifications present.

Identifiants

pubmed: 38010134
doi: 10.1021/jasms.3c00321
doi:

Substances chimiques

Capsid Proteins 0
Viral Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2811-2821

Auteurs

Jack P Ryan (JP)

University of North Carolina, Department of Chemistry, Chapel Hill, North Carolina 27599, United States.

Marius M Kostelic (MM)

University of Arizona, Department of Chemistry and Biochemistry, Tucson, Arizona 85721, United States.

Chih-Chieh Hsieh (CC)

University of Arizona, Department of Chemistry and Biochemistry, Tucson, Arizona 85721, United States.

Joshua Powers (J)

Institute for Bioscience and Biotechnology Research (NIST), Gaithersburg Maryland 20899, United States.
North Carolina State University, Biomanufacturing Training and Education Center (BTEC), Raleigh, North Carolina 27695, United States.

Craig Aspinwall (C)

University of Arizona, Department of Chemistry and Biochemistry, Tucson, Arizona 85721, United States.

James N Dodds (JN)

University of North Carolina, Department of Chemistry, Chapel Hill, North Carolina 27599, United States.

John E Schiel (JE)

Institute for Bioscience and Biotechnology Research (NIST), Gaithersburg Maryland 20899, United States.

Michael T Marty (MT)

University of Arizona, Department of Chemistry and Biochemistry, Tucson, Arizona 85721, United States.

Erin S Baker (ES)

University of North Carolina, Department of Chemistry, Chapel Hill, North Carolina 27599, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH